Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study

INTRODUCTION: The introduction of biological disease-modifying antirheumatic drugs (bDMARDs) has improved the treatment of inflammatory rheumatic diseases dramatically. However, bDMARD treatment failure occurs in 30%–40% of patients due to lack of effect or adverse events, and the tools to predict t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kringelbach, Tina Marie, Glintborg, Bente, Hogdall, Estrid V, Johansen, Julia Sidenius, Hetland, Merete Lund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829933/
https://www.ncbi.nlm.nih.gov/pubmed/29391382
http://dx.doi.org/10.1136/bmjopen-2017-019325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829933/
https://www.ncbi.nlm.nih.gov/pubmed/29391382
http://dx.doi.org/10.1136/bmjopen-2017-019325

Ejemplares similares